Retour
Fourchette du Jour
22,30 €
23,21 €
Fourchette 52 Semaines
18,80 €
27,64 €
Volume
751 463
Moyenne 50J / 200J
21,87 €
/
23,66 €
Clôture Précédente
22,65 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 141,9 | 0,4 |
| P/B | 1,4 | 2,9 |
| ROE % | 1,0 | 3,7 |
| Net Margin % | 1,0 | 3,9 |
| Rev Growth 5Y % | 7,6 | 10,0 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,95 €
4,87 € – 5,06 €
|
940 M | 2 |
| FY2029 |
4,60 €
4,52 € – 4,70 €
|
920 M | 2 |
| FY2028 |
5,18 €
5,10 € – 5,29 €
|
960 M | 3 |
Points Clés
Revenue grew 7,62% annually over 5 years — modest growth
ROE of 0,96% is below average
Generating 136,66M in free cash flow
P/E of 141,90 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,99%
Cash machine — converts 1942,86% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
7,62%
Revenue (1Y)3,63%
Earnings (1Y)N/A
FCF Growth (3Y)-1,02%
Qualité
Return on Equity
0,96%
ROIC1,84%
Net Margin0,97%
Op. Margin3,87%
Sécurité
Debt / Equity
0,66
Current Ratio4,54
Interest Coverage1,61
Valorisation
P/E Ratio
141,90
P/B Ratio1,44
EV/EBITDA46,04
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,63% | Revenue Growth (3Y) | 3,74% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -59,05% |
| Revenue Growth (5Y) | 7,62% | Earnings Growth (5Y) | -36,02% |
| Profitability | |||
| Revenue (TTM) | 726,41M | Net Income (TTM) | 7,03M |
| ROE | 0,96% | ROA | 0,56% |
| Gross Margin | 71,50% | Operating Margin | 3,87% |
| Net Margin | 0,97% | Free Cash Flow (TTM) | 136,66M |
| ROIC | 1,84% | FCF Growth (3Y) | -1,02% |
| Safety | |||
| Debt / Equity | 0,66 | Current Ratio | 4,54 |
| Interest Coverage | 1,61 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 141,90 | P/B Ratio | 1,44 |
| P/S Ratio | 1,37 | PEG Ratio | -1,53 |
| EV/EBITDA | 46,04 | Dividend Yield | 0,00% |
| Market Cap | 998,09M | Enterprise Value | 1,29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 726,41M | 700,97M | 674,98M | 666,82M | 541,53M |
| Net Income | 7,03M | -99,56M | 41,96M | 15,91M | 41,98M |
| EPS (Diluted) | 0,16 | -2,15 | 0,89 | 0,34 | 0,92 |
| Gross Profit | 519,37M | 530,54M | 490,31M | 467,53M | 401,28M |
| Operating Income | 28,10M | -73,37M | 87,68M | 60,02M | 89,92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,26B | 1,55B | 1,57B | 1,68B | 2,08B |
| Total Liabilities | 571,81M | 775,17M | 704,26M | 906,19M | 1,34B |
| Shareholders' Equity | 693,11M | 778,35M | 870,13M | 775,01M | 730,41M |
| Total Debt | 454,38M | 638,85M | 586,04M | 763,39M | 1,13B |
| Cash & Equivalents | 158,55M | 276,77M | 153,30M | 104,14M | 585,58M |
| Current Assets | 547,97M | 745,13M | 509,99M | 498,33M | 866,05M |
| Current Liabilities | 120,59M | 309,92M | 97,38M | 147,77M | 521,12M |